MICROENCAPSULATION OF BIFIDOBACTERIUM LACTIS Bi-07 WITH GALACTOOLIGOSACCHARIDES USING CO-EXTRUSION TECHNIQUE
Keywords:Microencapsulation, probiotic, co-extrusion, galactooligosaccharides, Bifidobacterium
Probiotics play an important role in human gut health. However, it remains a challenge to maintain the viability of probiotics throughout the gastrointestinal transit. Hence, this study aimed to microencapsulate Bifidobacterium lactis Bi-07 with galactooligosaccharides (GOS) using the co-extrusion technique. Optimization of calcium chloride (1.0% w/v to 3.0% w/v) and GOS concentration (1.0% w/v to 5.0% w/v) were performed in the encapsulation of B. lactis Bi-07 based on bead size and microencapsulation efficiency. The study found that microbead prepared with 1.5% (w/v) sodium alginate, 2.0% (w/v) calcium chloride and 3.0% (w/v) GOS showed the highest microencapsulation efficiency. The size of the bead produced was 735.69 μm with the highest microencapsulation efficiency of more than 94%. Besides, the microencapsulation efficiency and bead size were compared between B. lactis Bi-07 beads with or without GOS. Results showed that the encapsulated B. lactis Bi-07 with GOS was had a larger bead size and lower microencapsulation efficiency than encapsulated probiotic cells without GOS. Furthermore, the encapsulated B. lactis Bi-07 and free cells were subjected to simulated gastrointestinal treatment where the cell viability was evaluated. Encapsulated B. lactis Bi-07 with GOS showed higher cell viability than encapsulated B. lactis Bi-07 without GOS and free cells after the simulated gastrointestinal treatment. The viable cell count of encapsulated B. lactis Bi-07 with GOS remained more than 107 CFU/mL. This showed that the optimized encapsulated B. lactis Bi-07 with GOS could survive the human gastrointestinal to confer health benefits and the potential to be incorporated into functional foods.
How to Cite
Copyright (c) 2022 Pui Yin Lai, Yu Hsuan How, Liew Phing Pui
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers published in the Journal of Microbiology, Biotechnology and Food Sciences are published under a CC-BY licence (CC-BY 4.0). Published materials can be shared (copy and redistribute the material in any medium or format) and adapted (remix, transform, and build upon the material for any purpose, even commercially) with specifying the author(s).
Online Published 2022-06-02